| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 53 |
| 1 | ERGOCALCIFEROL | 52 |
| 2 | GABAPENTIN | 52 |
| 3 | ACETAMINOPHEN | 51 |
| 4 | PREGABALIN | 50 |
| 5 | OMEPRAZOLE | 45 |
| 6 | IBUPROFEN | 38 |
| 7 | ALBUTEROL SULFATE | 36 |
| 8 | TOPIRAMATE | 36 |
| 9 | ALPRAZOLAM | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SORBITOL | 7 | 0.0116 |
| 1 | ALMOTRIPTAN | 11 | 0.0104 |
| 2 | DIHYDROERGOTAMINE MESYLATE | 11 | 0.0082 |
| 3 | SELENIUM | 9 | 0.0021 |
| 4 | ERGOCALCIFEROL | 52 | 0.0017 |
| 5 | UBROGEPANT | 11 | 0.0017 |
| 6 | INFLIXIMAB-DYYB | 5 | 0.0015 |
| 7 | PRAZOSIN | 8 | 0.0013 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 5 | 0.0011 |
| 9 | INDOMETHACIN | 14 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 126 |
| 1 | Benzodiazepine [EPC] | 92 |
| 2 | Corticosteroid [EPC] | 87 |
| 3 | Proton Pump Inhibitor [EPC] | 60 |
| 4 | Provitamin D2 Compound [EPC] | 52 |
| 5 | Acetylcholine Release Inhibitor [EPC] | 38 |
| 6 | Estrogen [EPC] | 38 |
| 7 | Neuromuscular Blocker [EPC] | 38 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 35 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 35 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 15 | 0.0022 |
| 3 | Provitamin D2 Compound [EPC] | 52 | 0.0017 |
| 4 | beta Lactamase Inhibitor [EPC] | 4 | 0.0009 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 6 | Nonergot Dopamine Agonist [EPC] | 10 | 0.0006 |
| 7 | Barbiturate [EPC] | 7 | 0.0006 |
| 8 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 9 | Calcitonin Gene-related Peptide Antagonist [EPC] | 5 | 0.0005 |